File: A composite image of the company logos of Swiss-based Roche Holding, US company Pfizer and Aspen Pharmacare, Africa's biggest generic drug maker.
JOHANNESBURG - Aspen Pharmacare will split its South African Commercial Pharmaceuticals business into two divisions.In its half-year results statement, the company revealed that it was conducting a strategic review of its South African and European operations.It hopes the split will improve its focus on products and customers, but little detail was given as to what each division will include.
Aspen's normalised headline earnings per share for the six months which ended in December fell by 9% to 743,4 cents from 814,1 cents a year earlier.Normalised earnings before interest, tax, depreciation and amortisation from continuing operations fell 3% to R5,5-billion.
Atleast there will be a job CREATIONS in these areas,well appreciated.
I hope there will be more local ownership in the different entities